10 PHILD
DEAD

Serial Number

75142241

Owner

Phild Co., Ltd

Attorney

John T. Miller

Filing Date

Jul 26, 1996

Add to watchlist:

No watchlists yet
View on USPTO

10 PHILD Trademark

Serial Number: 75142241 • Registration: 2347940

10 PHILD is a trademark filed by Phild Co., Ltd on July 26, 1996. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Phild Co., Ltd (97 trademarks)

4th Fl., Kawamoto Bldg., 110
Kamigyo-ku Kyoto-city, Koyoto Pref , JP

Entity Type: 03

Trademark Details

Filing Date

July 26, 1996

Registration Date

May 9, 2000

Published for Opposition

February 15, 2000

Cancellation Date

February 17, 2007

Goods & Services

drugs for medical purposes, namely, drugs for central nervous system, namely, general anesthetics, hypnotics and sedatives, anti-epileptics, antipyretics and analgesics, nervous system stimulants, analeptics and anti-dizziness agents; drugs for peripheral nervous system, namely, local anesthetics, skeletal muscle relaxants, autonomics, antispasmodics, diaphoretics and anhidrotics; drugs for sensory organs, namely, agents for ophthalmic use and agents for otic and nasal use; drugs used in allergy, namely, anti-histamines and agents for stimulation therapy; drugs affecting circulatory organs, namely, cardiotonics, agents for arrhythmia, diuretics, hypotensors, vasosupporters, vasoconstrictors and cerebral hemorrhage prophylactic; agents affecting respiratory organs, namely, respiratory stimulants, antitussives and expectorants and cough wheat gluten; agents for digestive organs, namely, agents for dental use, agents for oral use, stomachics and digestives, antacids, anti-emetics, emetics, choleretics, antidiarrheals, purgatives, clysters, stomach and bowels wash powder, tooth prophylactic, stomatic refrigerant, and stomatic cleanser; hormone preparations, namely, pituitary hormone preparations, salivary gland hormone preparations, thyroid and accessory thyroid hormone preparations, pancreas hormone preparations, adrenal hormone preparations, androgens, estrogens and mixed hormone preparations; agents for urinary, genital and anal organs, namely, urinary antiseptics, oxytocics, agents affecting menstruation, contraceptives and anti-hemorrhoidics; agents affecting epidermis, namely, disinfectants, dermatics for purulence, analgesics, anti-itchings, astringents, cataplasms, anti-dermoinfectives, corrosives, hair remedies, bath preparations, medicated baby powder, medicated baby oil, medicated soap of the Japanese pharmacopoeia; vitamin preparations, namely, vitamin A preparations, vitamin B preparations, vitamin C preparations, vitamin D preparations, composite vitamin preparations compounded of water soluble and fat soluble vitamins, mixed vitamin preparations compounded of water soluble and fat soluble vitamins and cod-liver oil drops; amino acids and preparations, namely, lysine, methionin, tryptophane and threonine; preparations, nutrients, tonics and alternatives, namely, calcium, mineral, saccharide, organic acid, proteins, amino acids, organotherapeutics, chondroitin, foodstuff solidifying agent, medicated wine and royal jelly; agents relating to blood, namely, blood substitutes, hemostatics, anticoagulants and blood-plasma; agents affecting metabolism, namely, lipotropic factor preparations, antidotes, agents for treatment of habitual intoxication, lactogoques and enzyme preparations; agents for activating cellular function, namely, chlorophyll preparations and dyes; anti-cancer and anti-sarcoma tumor suppressing agents; agents used in lesion due to physical stimuli, namely, agents used in thermoplegia and agents used in radiation sickness; agents used in lesion due to chemical stimuli, namely, anti-benzolismus, anti-arsenium and anti-chlorine poisoning; antibiotics and preparations, namely, penicillin, streptomycin, chloramphenicol, erythromycin, thiolutin, tetracycline, colistin-polymyxin, mixed antibiotic, salkomycin and trichomycin; chemotherapeutics agents and preparations, namely, sulfonamide, antituberculotic, antisyphilitics and antiliprotic; biological products, namely, vaccines, toxins, toxoids, antitoxins, antibacterial sera, diagnostic acids for biological tests and mixed biological preparations; agents against parasites, namely, antiprozoals and anthelmintics; agents for dispensing use, namely, excipients, ointment bases, solvents, flavoring agents, deodorizer and coloring agents; diagnostic aids, namely, X-ray contrast media, diagnostic reagents and diagnostic media; labeled isotope substance for treatment and diagnosis; narcotics, namely, opium alkaloids, derivatives and preparations, coca alkaloids, derivatives and preparations and synthetic narcotics; crude drug, charred drug and moxa; veterinary drugs; agents for agriculture or public health, namely, disinfectants, insecticides, fumigants, rodenticides, herbicides, germination controllers, hormones for plants, plants rearing agents, soil improving agents, moth repellents, deodorants and antiseptics; dental restoration compounds, namely, dental cements, dental prosthetic and filling materials; oblates, namely, thin wafers made from wheatmeal or capsules for the purpose of wrapping the aforementioned drugs for medical purposes; gauze; capsules for containing aforementioned drugs for medical purposes; ear bandages; menstruation tampons; sanitary napkins; panties incorporating sanitary pads; absorbent cotton for medical purposes; adhesive medical plasters; bandages for dressings; liquid wound dressings; adult diapers; semen for artificial insemination; powdered milk for babies; menstruation bandages

dental wax and artificial tooth materials; medical oil paper used for medical purposes; sanitary masks used by people with colds or other contagious illnesses; eye patches; bracelets, namely, orthopedic supporters for medical purposes

Filing History

CANCELLED SEC. 8 (6-YR)
Feb 17, 2007 C8..
CASE FILE IN TICRS
Apr 14, 2006 CFIT
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 16, 2004 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 6, 2004 TCCA
REGISTERED-PRINCIPAL REGISTER
May 9, 2000 R.PR
PUBLISHED FOR OPPOSITION
Feb 15, 2000 PUBO
NOTICE OF PUBLICATION
Jan 14, 2000 NPUB
Sec. 1(B) CLAIM DELETED
Oct 23, 1999 1.BD
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 1, 1998 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 5, 1998 CRFA
LETTER OF SUSPENSION MAILED
May 20, 1998 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 13, 1998 CRFA
FINAL REFUSAL MAILED
Oct 10, 1997 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 1997 CRFA
NON-FINAL ACTION MAILED
Feb 11, 1997 CNRT
ASSIGNED TO EXAMINER
Jan 16, 1997 DOCK
ASSIGNED TO EXAMINER
Jan 10, 1997 DOCK